Search Results - "Illiger, H J"

IL-2 in combination with IFN-α and 5-FU versus tamoxifen in metastatic renal cell carcinoma : long-term results of a controlled randomized clinical trial by ATZPODIEN, J, KIRCHNER, H, PATZELT, T, REITZ, M, ILLIGER, H. J, METZNER, B, UKENA, D, SCHOTT, H, FUNKE, P. J, GRAMATZKI, M, VON JÜRGENSON, S, WANDERT, T

“…We conducted a prospectively randomized clinical trial to compare the efficacy and safety of subcutaneous interferon-alpha2a, subcutaneous interleukin-2 and…”
Get full text

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer by Heinemann, V., Wilke, H., Mergenthaler, H.-G., Clemens, M., König, H., Illiger, H. J., Arning, M., Schalhorn, A., Possinger, K., Fink, U.

“…Background This phase II study was initiated to determine the efficacy and safety of gemcitabine plus cisplatin in patients with pancreatic cancer. Patients…”
Get full text

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma by Atzpodien, J, Lopez Hänninen, E, Kirchner, H, Bodenstein, H, Pfreundschuh, M, Rebmann, U, Metzner, B, Illiger, H J, Jakse, G, Niesel, T

“…In a phase II multiinstitutional outpatient trial, patients with progressive metastatic renal cell carcinoma were treated with a combination of subcutaneous…”
Get more information

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen by Ho, A D, Lipp, T, Ehninger, G, Illiger, H J, Meyer, P, Freund, M, Hunstein, W

“…Both mitoxantrone and etoposide have been shown to be active in monotherapy trials of relapsed and refractory acute myelogenous leukemia (AML). This phase II…”
Get more information

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO) by Weh, H J, Wilke, H J, Dierlamm, J, Klaassen, U, Siegmund, R, Illiger, H J, Schalhorn, A, Kreuser, E D, Hilgenfeld, U, Steinke, B

“…No effective salvage therapy is known for patients with metastatic colorectal carcinoma progressive after chemotherapy with 5-fluorouracil (5-FU)/folinic acid…”
Get more information

Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantation by Sezer, O, Possinger, K, Metzner, B, Illiger, H J, Wattad, M, Heit, W, Fuss, H, Schultze, W

Get full text

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia by Hofmann, W K, Seipelt, G, Langenhan, S, Reutzel, R, Schott, D, Schoeffski, O, Illiger, H J, Hartmann, F, Balleisen, L, Franke, A, Fiedler, F, Huber, C, Rasche, H, Bergmann, L, Ganser, A, Pott, C, Pasold, R, Rudolph, C, Ottmann, O G, Gökbuget, N, Hoelzer, D

“…In acute lymphoblastic leukemia (ALL), treatment with granulocyte colony stimulating factor (G-CSF) during remission induction shortens granulocytopenia and…”
Get full text

ASHAP: an effective salvage therapy for recurrent and refractory malignant lymphomas by HÄNEL, M, KRÖGER, N, KRÜGER, W. H, ZELLER, W, WEH, H, HOSSFELD, D. K, ZANDER, A. R, HOFFKNECHT, M. M, PETERS, S. O, METZNER, B, FIEDLER, F, BRAUMANN, D, SCHUBERT, J. C, ILLIGER, H. J, HÄNEL, A

“…This study was performed to examine the efficacy and toxicity of the combination of adriamycin (ADR), methylprednisolone (solumedrol), cytarabine (Ara-C), and…”
Get full text

High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission by Zander, A R, Berger, C, Kröger, N, Stockshläder, M, Krüger, W, Horstmann, M, Grimm, J, Zeller, W, Kabisch, H, Erttmann, R, Schönrock, P, Kuse, R, Braumann, D, Illiger, H J, Fiedler, W, de Witt, M, Hossfeld, K D, Weh, H J

“…We explored the combination of busulfan/cyclophosphamide/etoposide as conditioning regimen prior to bone marrow transplantation in 31 patients with acute…”
Get full text

Epirubicin and ifosfamide in metastatic breast cancer by Becher, R, Kloke, O, Hayungs, J, Hartwich, G, Bartels, H, Szanto, J, Wolf, E, Illiger, H J, Halabi, S, Rieche, K, Hering, K G, Ohl, S, DeDycker, R, Huhn, R, Fischedick, A R, Höfeler, H, Pielken, H J, Hawig, I, Hirche, H, Seeber, S

“…In a randomized, phase II trial, we evaluated the effectiveness of continued chemotherapy with epirubicin/ ifosfamide versus unmaintained treatment…”
Get more information

Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma by Probst‐Kepper, Michael, Schrader, Andres, Buer, Jan, Grosse, Jens, Volkenandt, Matthias, Illiger, Hans‐Joachim, Metzner, Bernd, Kadar, Janosch, Duensing, Stefan, Hertenstein, Bernd, Ganser, Arnold, Atzpodien, Jens

“…The detection of melanocyte‐specific messenger RNA in patients with malignant melanoma suggests the potential contamination of peripheral blood stem cell…”
Get full text

Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma by HARSTRICK, A, SCHMOLL, H.-J, SONNTAG, R, HARTENSTEIN, R, CLEMM, C, WILK, H, POLIWODA, H, BOKEMEYER, C, METZNER, B, ILLIGER, H.-J, BERDEL, W, OSTERMANN, H, MANEGOLD, C, RÄTH, U, SIEGERT, W

“…In order to develop a more dose-intensive induction regimen for the treatment of far-advanced testicular tumours, the German Cooperative Group for Testicular…”
Get full text

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours by Bokemeyer, C, Schmoll, H J, Harstrick, A, Illiger, H J, Metzner, B, Räth, U, Hohnloser, J, Clemm, C, Berdel, W, Siegert, W

“…In order to improve the survival of patients with metastatic advanced disease germ cell tumours (according to Indiana University classification), 77 patients…”
Get more information

Comparison of 5 vs 10 μg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer by BOKEMEYER, C, SCHMOLL, H.-J, METZNER, B, BEYER, J, ILLIGER, H. J, KNEBA, M, OSTERMANN, H, KYNAST, B, RÄTH, U, POLIWODA, H

Get full text

Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lung by SCHMIDT, R. E, HARTLAPP, J. H, NIESE, D, ILLIGER, H. J, STROEHMANN, I

“…Thirty-two patients with small cell carcinoma of the lung received intensive induction chemoradiotherapy. In a randomized prospective study, we compared the…”
Get full text

Drug interactions in the therapy of malignant diseases: H.J. Illiger, K. Herdrich by Illiger, H. J, Herdrich, K

Get more information

Alternatives to CYVADIC combination therapy of soft tissue sarcomas by Hartlapp, J H, Münch, H J, Illiger, H J, Wolter, H, Jensen, J C

“…The CYVADIC combination has been the preferred treatment for soft tissue sarcomas for the last 10 years. Other combination therapies are necessary, because the…”
Get full text

Lectin-independent, irreversible redistribution of concanavalin A receptors on influenza virus infected Ehrlich ascites tumor cells by Fresen, K O, Illiger, H J

Get full text

Alternatives to CYVADIC-combination therapy of soft tissue sarcomas by Hartlapp, J H, Münch, H J, Illiger, H J, Wolter, H, Jensen, J C

“…The CYVADIC combination has been the preferred treatment for soft tissue sarcomas for the last 10 years. Other combinations of therapy are necessary because…”
Get full text

Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum by Fritze, D, Massner, B, Becher, R, Kaufmann, M, Illiger, H J, Hartlapp, J, Queisser, W, Abel, U, Edler, L, Mayr, A C

“…From January 1978 to December 1980, 222 patients with metastatic breast cancer were included into a prospective multicenter trial. All patients were treated…”
Get full text